Advertisement
Not a member of Pastebin yet?
Sign Up,
it unlocks many cool features!
- Received: from DM6PR04MB4699.namprd04.prod.outlook.com (2603:10b6:0:56::11) by DM6PR04MB4700.namprd04.prod.outlook.com with HTTPS via DM3PR12CA0043.NAMPRD12.PROD.OUTLOOK.COM; Fri, 30 Nov 2018 21:09:26 +0000 Received: from CY4PR04CA0031.namprd04.prod.outlook.com (2603:10b6:903:c6::17) by DM6PR04MB4699.namprd04.prod.outlook.com (2603:10b6:5:1e::20) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.1361.19; Fri, 30 Nov 2018 21:09:24 +0000 Received: from CO1NAM04FT041.eop-NAM04.prod.protection.outlook.com (2a01:111:f400:7e4d::205) by CY4PR04CA0031.outlook.office365.com (2603:10b6:903:c6::17) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.1382.18 via Frontend Transport; Fri, 30 Nov 2018 21:09:24 +0000 Authentication-Results: spf=softfail (sender IP is 170.212.0.125) smtp.mailfrom=fivefivecollective.com; PennMedicine.mail.onmicrosoft.com; dkim=fail (signature did not verify) header.d=fivefivecollective.com;PennMedicine.mail.onmicrosoft.com; dmarc=none action=none header.from=fivefivecollective.com; Received-SPF: SoftFail (protection.outlook.com: domain of transitioning fivefivecollective.com discourages use of 170.212.0.125 as permitted sender) Received: from pennmedicine.upenn.edu (170.212.0.125) by CO1NAM04FT041.mail.protection.outlook.com (10.152.91.18) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA384) id 15.20.1382.18 via Frontend Transport; Fri, 30 Nov 2018 21:09:24 +0000 Received: from UPHMASPHI030.UPHS.PENNHEALTH.PRV (170.212.133.112) by smtphybrid.pennmedicine.upenn.edu (170.212.240.27) with Microsoft SMTP Server (version=TLS1_0, cipher=TLS_ECDHE_RSA_WITH_AES_256_CBC_SHA_P256) id 15.1.845.34; Fri, 30 Nov 2018 16:08:49 -0500 Received: from uphsmtpvaplt03i.uphs.upenn.edu (170.212.137.221) by UPHMASPHI030.UPHS.PENNHEALTH.PRV (170.212.133.112) with Microsoft SMTP Server (TLS) id 14.3.408.0; Fri, 30 Nov 2018 16:08:51 -0500 X-IronPort-AV: E=Sophos;i="5.56,299,1539662400"; d="pdf'?scan'208,217";a="2945487" X-Amp-Result: LOWRISK X-Amp-File-Uploaded: False X-MGA-submission: =?us-ascii?q?MDGF/RF2LmVnZw2O2tl29Z+tTd7PVds6wWVVMW?= =?us-ascii?q?yu2MLdoGQtyrdMNwRZ0vAbsJW+6I/n72CDSaqUXaJG+maO2OOdIAfcMT?= =?us-ascii?q?K21oMAmSY2aOKOKsEjA4pLvlP71B+N4X8zT+7IseEs0PlkRK8X5LNhbT?= =?us-ascii?q?Ly?= Received: from mta-07-4.privateemail.com ([68.65.122.27]) by UPSMTPVAPLT03O.uphs.upenn.edu with ESMTP/TLS/DHE-RSA-AES256-GCM-SHA384; 30 Nov 2018 16:08:45 -0500 Received: from MTA-07.privateemail.com (localhost [127.0.0.1]) by MTA-07.privateemail.com (Postfix) with ESMTP id 6E39460046; Fri, 30 Nov 2018 16:08:39 -0500 (EST) DKIM-Signature: v=1; a=rsa-sha256; c=simple/simple; d=fivefivecollective.com; s=default; t=1543612122; bh=C8Sf1V4FkRfNEb1+fPPGQfF6xm0wreL/6Tg8CrBvEmI=; h=References:In-Reply-To:From:Date:Subject:To:Cc:From; b=uCzywkhy+2XPsVgJcPaS1225FVv8j/ioVY8583FzOz+VwYMfQTzehZQqel+VFOyC0 4P5xFtg5Jj2jdRWX2CKVWn8uu50NUmaVRJxb41LX/A9rg9+nh12yXx2OizOL7M0cgQ Zyed2fLtzrMmTTUs+9ZDcFL3ZEvwk8xK84B2gquo= Received: from mail-ua1-f49.google.com (unknown [10.20.151.212]) by MTA-07.privateemail.com (Postfix) with ESMTPA id C188760034; Fri, 30 Nov 2018 21:08:34 +0000 (UTC) DKIM-Signature: v=1; a=rsa-sha256; c=simple/simple; d=fivefivecollective.com; s=default; t=1543612117; bh=C8Sf1V4FkRfNEb1+fPPGQfF6xm0wreL/6Tg8CrBvEmI=; h=References:In-Reply-To:From:Date:Subject:To:Cc:From; b=eK8FQCz00GMXSnY8vf1eoFBYHwwCGJzrLTE9R3U3yoS9VvEp2ytzdyWrvHRBcjmRa Jd7PSPCaBDpwr6NQbFHHVi8nFPxPumAs0SF8XSKyiDjNoRB3BRyLwYhWRS2XVXfW+k xF5otPsCi8YcZHmQ544zn8PSZWJcVnFKmspYdR5s= Received: by mail-ua1-f49.google.com with SMTP id e16so2365786uam.12; Fri, 30 Nov 2018 13:08:34 -0800 (PST) X-Gm-Message-State: AA+aEWaMxK+ziKHwFQP60EXE3z8oa8jQ31DB8mB9+d3AymuMtd2RRux4 TEjtknvd3r0IVRKLvXLj5SkfEFLkce72Sj4E9gQ= X-Google-Smtp-Source: AFSGD/UHgoDMQCfypIZTHLJFB8q6fOiujd2QOmdsBz6G7PrHv3WVfVFeF2WZEvIa2zg9X5Eni51TO7bx9NYb6FLqGwg= X-Received: by 2002:ab0:6392:: with SMTP id y18mr3298491uao.12.1543612113535; Fri, 30 Nov 2018 13:08:33 -0800 (PST) MIME-Version: 1.0 References: <SN6PR04MB4366261F8B9924AF53C9F618D3CB0@SN6PR04MB4366.namprd04.prod.outlook.com> <CAMKk09L5mcrFrWj6-yfKL=KrPxawiTGuC5PJo0U3g352=eiTTA@mail.gmail.com> <SN6PR04MB4366C42ECAF89D4494387643D3C50@SN6PR04MB4366.namprd04.prod.outlook.com> <4FCDBAF4-EA66-4835-A33C-B7AFB265E8CA@pennmedicine.upenn.edu> <CAMKk09+H74nwr0=wEc6YqM3VhUu-dGLUYfE5+HxatX7F0H2wjQ@mail.gmail.com> <SN6PR04MB52958036546894906C3DC3BFD3DD0@SN6PR04MB5295.namprd04.prod.outlook.com> <CAMKk09KGQ+qqYk3z+Zy+=oGqGgvdG7iUpsgKbAPak5te9TnCdQ@mail.gmail.com> <SN6PR04MB529578F0B4033FE4459EE019D3D30@SN6PR04MB5295.namprd04.prod.outlook.com> In-Reply-To: <SN6PR04MB529578F0B4033FE4459EE019D3D30@SN6PR04MB5295.namprd04.prod.outlook.com> From: Dan Leung <dan@fivefivecollective.com> Date: Fri, 30 Nov 2018 16:08:21 -0500 X-Gmail-Original-Message-ID: <CAMKk09KsnCv7CgimhmdjB33WuDoPS25xFWHNvn3_1DdZ_b92fw@mail.gmail.com> Message-ID: <CAMKk09KsnCv7CgimhmdjB33WuDoPS25xFWHNvn3_1DdZ_b92fw@mail.gmail.com> Subject: Re: [External] Re: 2018-19 Accelerator Fund Videos To: <Phillip.Stoltzfus@pennmedicine.upenn.edu> CC: Max Goldberg <max@fivefivecollective.com>, "Curran, Matt" <Matt.Curran@pennmedicine.upenn.edu> X-Virus-Scanned: ClamAV using ClamSMTP Return-Path: dan@fivefivecollective.com X-OrganizationHeadersPreserved: UPHMASPHI030.UPHS.PENNHEALTH.PRV X-MS-Exchange-Organization-ExpirationStartTime: 30 Nov 2018 21:09:24.2853 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 2:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: b3729d3a-300e-4d9f-e327-08d657081af0 X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-CrossPremisesHeadersPromoted: CO1NAM04FT041.eop-NAM04.prod.protection.outlook.com X-CrossPremisesHeadersFiltered: CO1NAM04FT041.eop-NAM04.prod.protection.outlook.com X-Forefront-Antispam-Report: CIP:170.212.0.125;IPV:NLI;CTRY:US;EFV:NLI;SFV:SPM;SFS:(2980300002)(3190300001)(199004)(189003)(55674003)(252514010)(84326002)(1096003)(733005)(606006)(966005)(71190400001)(498394004)(86362001)(61266001)(28085005)(575784001)(6916009)(450100002)(63106013)(8676002)(8936002)(3672435006)(476003)(93886005)(116002)(126002)(4006027)(21480400003)(61726006)(486006)(4744004)(14444005)(5024004)(217443001)(567704001)(356004)(6666004)(5660300001)(336012)(33964004)(246002)(53946003)(16586007)(345774005)(4326008)(42186006)(95326003)(15974865002)(93516011)(446003)(11346002)(53376002)(53546011)(9686003)(8576002)(6306002)(236005)(229853002)(105596002)(55446002)(2171002)(156004)(2351001)(26005)(305945005)(7636002)(2476003)(76176011)(6246003)(54906003)(106466001)(33896004)(109096001)(568964002)(44180200008);DIR:INB;SFP:;SCL:5;SRVR:DM6PR04MB4699;H:pennmedicine.upenn.edu;FPR:;SPF:SoftFail;LANG:en;PTR:eop-outbound-2.pennmedicine.upenn.edu;A:1;MX:1;CAT:SPM; X-Microsoft-Exchange-Diagnostics: 1;CO1NAM04FT041;1:hR53roSNN4raku91yQr2UmD5zfLGQo+bB8cedly76xeWSx48QYdDvuUs9F0kVx4g4YSdOTjBcFO4yoe8/s/UFcwtmQBOESa5R0rd7RhxGFPG6rJQU9KiLNxdNx2T44Xe X-MS-Exchange-Organization-AuthSource: UPHMASPHI030.UPHS.PENNHEALTH.PRV X-MS-Exchange-Organization-AuthAs: Anonymous X-OriginatorOrg: pennmedicine.upenn.edu X-MS-PublicTrafficType: Email X-MS-Office365-Filtering-Correlation-Id: b3729d3a-300e-4d9f-e327-08d657081af0 X-Microsoft-Antispam: BCL:0;PCL:0;RULEID:(2390098)(7020095)(4652040)(8989299)(5600074)(711020)(4534185)(4627221)(201703031133081)(8559020)(8990200)(2017052603328)(7153060)(49563074);SRVR:DM6PR04MB4699; X-Microsoft-Exchange-Diagnostics: 1;DM6PR04MB4699;3:eZ8+eAm2HL3mvqONc1TsoQPQS41LI2tSQIj4V+4UUzD5IyfqF3TPrAWMa8svuKxBVU1NDHJGyZ48eENlQHHSU7NyN8h2hqqksm0QEimp+FLdAcvyS2VI+PnESgLO8GkMMS89bxhzHLy0E052HpjNttRQBAw1NEBON0iQ7exi/aO2j1MzkRtLcl2POo7n54vax5L/Yz4W+ac7zYhi0zKDhBDhOprsrVMOIwnri7IgD6N5EYWhPx0bCcUkJ1a38OHanV4q+UeYHxsRJgWgVN5+pzhM+RCtN9rPg3V+/HP89yqDSPrLBcewXk2eqAxURnlrxVVZd8/VO3Fk1QxlQlB/xtnqPgesB+cLahdTlJQoKkE=;25:c2Jt07pdXCcsPFvRs2vp9xrIQUQuG1WwBFw8ziXAs0r3+KNS9gEmVZ/ObyNcRLRHcTDOHe4lJ2NFDI7Rpp5gYxcQvcG4Hnn8BjvaVvA71bm0fs/cf48fnkyMbw6Y+rvIowDkISQers4HIp5R6D3Amj8RZd+jxKFs9/hc4gQH1p7g+hkaGzg8ontKH0boxCrFDvsjjKXPvG+Mp/LpkXI2sGRUExBsNv+kW7qih40y2lKVARQWcV3oYptBWb39DV6+8xCm17/+4QBTw0kF7A+9I4t5xqdjQmi5gu4JFPB3elNmi306/YT3DBdPfAuOoVU4zsvqhFwzRytbORgrC0UBUw== X-MS-TrafficTypeDiagnostic: DM6PR04MB4699: X-Microsoft-Exchange-Diagnostics: 1;DM6PR04MB4699;31:GfdZBeTLBmNZ5miNyOHVUHrUjuhLaM8SM0e+PQE6DO8Rna7WeEqXV2rS/aAkU49GtqAdoW9YHGWjtH9yMTeLJN+Ms4mRHWkJb33IhczIa1DFkG9ImlCNj9P4UH1b7+in7G8IrU5X8R4nLxqZdgQpzi3Ab/3KI8vyg6jNmUJYrHeqnrhYJNoQ44udyTWzhBTuaqUtv5eKPjU+gp4f1b3fXlIt9ruqEnGABk6FZWCjIvA=;20: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 X-Exchange-Antispam-Report-CFA-Test: =?us-ascii?Q?BCL:0;PCL:0;RULEID:(102415395)(2018062399030)(2018011200283)?= =?us-ascii?Q?(2401047)(920007026)(8121501046)(52410047)(2018011210174)(20?= =?us-ascii?Q?18011211064)(2018011212028)(2018011213028)(2018011214028)(20?= =?us-ascii?Q?18011215028)(2018011216028)(2018011217028)(2018011218028)(20?= =?us-ascii?Q?18011219092)(2018011220252)(2018011221063)(2018011222027)(20?= =?us-ascii?Q?18011223027)(2018011224027)(2018011225035)(2018011229035)(20?= =?us-ascii?Q?18011232269)(2018011233052)(2018021202149)(98810176)(2018021?= =?us-ascii?Q?203149)(98815176)(823300264)(823336083)(823350541)(823411253?= =?us-ascii?Q?)(3002001)(3231453)(901025)(902075)(913088)(999002)(7045084)?= =?us-ascii?Q?(11241501185)(944501469)(9300010059)(9301004368)(4983020)(49?= =?us-ascii?Q?82022)(52103095)(52105112)(52106170)(52408095)(98821027)(988?= =?us-ascii?Q?22027)(52401380)(52601095)(52606095)(52606095)(52606095)(526?= =?us-ascii?Q?06095)(52606095)(52606095)(52606095)(52606095)(52606095)(525?= =?us-ascii?Q?05095)(52406095)(52305095)(52206095)(88860335)(2017080701022?= =?us-ascii?Q?)(93006095)(93003095)(10201501046)(12181506113)(1610001)(830?= =?us-ascii?Q?1001075)(8301003183)(148016)(201708071742011)(7699051)(76991?= =?us-ascii?Q?095);SRVR:DM6PR04MB4699;BCL:0;PCL:0;RULEID:;SRVR:DM6PR04MB46?= =?us-ascii?Q?99;?= X-Microsoft-Exchange-Diagnostics: 1;DM6PR04MB4699;4:1+GtS3S8Q0m+lJUj7nQHv8fyOH1uhWzfdrpXe0ub3lIQ8+950+3Ejpn8k8UkU9H7S64tIX/E+WiB3d8QM+5sqZPpK+iCL5brnWNyPK49aDMBGKxXBChzBaiN2YW7F3jCgNjX19THiht4pvVzjudHFfLCt3WQ5LKoo8UouJk8Aw9TPqyuiv7DXksPfNWihHooTJ6n19ySLdZfD4f046ryBHak7/wxNJolkhP16fCWIWXUQ9HvLacbOUZMn5KOUSias80+XyiZ+6E9NwWV/6HgpQ== X-MS-Exchange-Organization-SCL: 5 X-Microsoft-Exchange-Diagnostics: =?us-ascii?Q?1;DM6PR04MB4699;23:n5Gck6L3I7shzI90gyD0Y4l+NAhJkIZu0zmGgN87i?= =?us-ascii?Q?iq8F8PC4L6Ynrzks/GBhUSctF316+fNbhJ9RH8XuIcskAdAumVhdjoeqXI0+?= =?us-ascii?Q?66sAxLfh2HBBmATxFZzWfaz9zNR1yckOk5AiEgRWxjFZ6OTsbOQbgDTTtBn6?= =?us-ascii?Q?2Yz66DdOEKv6PSKA5Sk7bep9zh5wnKCPyu0IHBV9iYYo7opWLnfHHqVyXIst?= =?us-ascii?Q?GxUeG/jXiYWxt8bz8DJuAfQ7cVXVEv46VAitPlOQMrVC5ODrb4ujokXzjuBk?= =?us-ascii?Q?YLtI6Py563XA21f5Pc+fpJwYvumDdX6aIZnzdKbh+OPaUh6B1M9sJs1L8E0E?= =?us-ascii?Q?HPoBzqEi1yfGYReauy5u2uBeRaHn3JOy8ESyjR2lJ4pDtauRHPbbQH8C+/eq?= =?us-ascii?Q?p5pQzK7UdAzIwAj1wVwqWAXx2k5kWycCe0mFsCzcDf3ruXWXddqGzOoq5ECD?= =?us-ascii?Q?qdRvFfaZqBfQ2mOq1iVGALUpBgWFet/ppJkUFujD9VPtaRlaX3nAvvcq1/VK?= =?us-ascii?Q?I8mqRcAv6pSPu607hVfpYURmdhinfqdXGb3EivQljIvmjZWAdGUfmwXd8tyi?= =?us-ascii?Q?6jm9Sp8ao2s3uKuo500suDiLhXC8zssAXfl3GNFRtDMPJyU6Y9CfNvMn7BoC?= =?us-ascii?Q?NJkxYK8Ik+sPoJld+K75hpbSfEiHH0Iq5CxiyHEwtodt4jVpyOLkbCjScDfv?= =?us-ascii?Q?6UWx4DBtCKuQsVHb95koAP2SaDZHVbrgAcQnn2orymmSZYhxO7Gn/1DDwytZ?= =?us-ascii?Q?H9JgjMI3Dg0XhElKyvlEY3kthFyPYocAVCnrUDHEUfOFkaJWzLUqCAqZXFzS?= =?us-ascii?Q?whCHnoLrj84rEggxJ+NjfsLwF0/2ubpoZm9QKr4vQLcdOlwaiIEHAgDV2n2v?= =?us-ascii?Q?v027yf4RVztVoeWA85sTIMa3myrrUmDLa2hH2bWC1pUpRM3KlTSGa66dz60/?= =?us-ascii?Q?xpsYCx91LT3onG7UGmwO3ce8Oi39MqDJgx7stz2Io+1HtPmfPP0tLsDysfV5?= =?us-ascii?Q?xbcgXIL+v26g1/a5jfI9oWZ8n8a59keDCPUR5K5y3fkyh972gEv0tSjY84s5?= =?us-ascii?Q?wY8+48cnKQi0yiFJoxQTqWp9L3JDQykoDEM5ibOY6gK9hSDoO2ybY22DpDoE?= =?us-ascii?Q?55hesovxJlm9FdS5omz0+r2O4WpRTdjSDD7Hf6XzoKOl2+3KQ1Jy8cd7NY0t?= =?us-ascii?Q?ztzWoXzb4anP2A0MSjWnJXHAlJHoVz9s9Hd1E4M1DoPOKdy64LtkpTX1O3xc?= =?us-ascii?Q?qRPPoIRgALYz9wb4LTV23ZytUxqFSQxUO3wVYe9TtL5Ifa6G/IAudHwA00pW?= =?us-ascii?Q?78t6OIsINexyo9n+5YKiDKNATl/Y0gSniRQy39HWqWei5ylgK6fVkHrAS9S1?= =?us-ascii?Q?tcMxl6s7AdH6NCyB08WvAqVW1BUBPXydXgZpdszv37s42RjlAqfBaCS+WxJP?= =?us-ascii?Q?gtGX2d/3P6s/0U7NUxnXZDHx8fCqObwA5DOSbh0mHYf7rpqLjEtAW9aTDbbm?= =?us-ascii?Q?YSe0bqwEBOQxsn0/tm211TzeaeAVJV06pOwUplxTO68B2LoL+x60Wg/Ajkpy?= =?us-ascii?Q?agjcQvibVCy3nDHSQ9dmwz5IfYtZ+jCRwfooraPAE3M0Nf31i4cTwOq2rrVi?= =?us-ascii?Q?oGKNLAyLTWKJM/fqcPXsKs5OuC0h+CStsKFjykUeZF6EaqZqM0LS8mMD7Aus?= =?us-ascii?Q?peS6WbKE5j3jPVY3Yq9NlL1Gn+1J5vL6JLqDseyk1mhOW4tcBTPFqlNrfE/v?= =?us-ascii?Q?BokDvV5?= X-Microsoft-Exchange-Diagnostics: 1;DM6PR04MB4699;6:J8IwpGpmfZiyQ7CD1YNNyFRwNEHFYf5ic8baErpktJZrlRpUNtMsPfZYFnU1PrnDQYGYZpNLmHB2ZQmXqItG+Behd5uguMnhr9GpVT8+Nl/+aLJS/U2dtszZOgXWyFdLzZjkV+zVUec24rg2yJ066Zu/q0dgeqFNR8prbn58+VBapGpX9/M/4LVGVplJwNA7M6WlM4PuF4T+02FN0kwzjWcY/eSBj9Ih310DjVyT8eUuFQHxZrSKiGd87rxLtWrgSACd1+QIzRSMOMupkgQR3I1DgPo6G5RzOOWu9Se7/ONOXfT5zRmHZB3Fd1HC/cGuJLn5FBdanptYPvhKBOb1XQU7i+ZBmKgDJOmBfw12LJJsiSolklSio1nsbl6R/FaLS4rjadlS3hhFoU3/rRhNmhak4jVtReedznDHBhb2s4wq4s7P98+6bE2vbb7cklwZ3VTUhYt5VdyOtYcne0DbviyZWQuPz9odWSEdSBup8B8dbdR8JhN3imdp1Yziv84Y;5:J0ZanJQTEpyaIoWnRQQi6QQrM5gUOZx60jXqJw/B8unHS/ksGPIFrahg0M8D5SRfMz/BBrFj17gWgLjBaUs9sbuAHRUuH74aWhglqZRmmuXvk8/QfCsqtpQTnQVoGxKoqJVh6mGDnWZWOFSxJYot6uXCC2AFr25aIgr5jqH48rQ=;7:a6sB1w86FfjlIxgN/BypYmSxByG8cxOBehmtLPTNgLOCx/O7Li4wGruJfuwpcDsOtA4j09fPpCEwIcRW6rLKhUVLQySdoKy70v83jSycq/99tuTGNMScSY7/cfx9E9iFDnM8J8B2OS0aBx9bubjH6g== SpamDiagnosticOutput: 1:22 SpamDiagnosticMetadata: Default X-MS-Exchange-CrossTenant-OriginalArrivalTime: 30 Nov 2018 21:09:24.0821 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: b3729d3a-300e-4d9f-e327-08d657081af0 X-MS-Exchange-CrossTenant-Id: 58e32bb7-141e-4bae-af01-f29f2a6613c2 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=58e32bb7-141e-4bae-af01-f29f2a6613c2;Ip=[170.212.0.125];Helo=[pennmedicine.upenn.edu] X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-CrossTenantHeadersStamped: DM6PR04MB4699 X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.7859858 X-MS-Exchange-Processed-By-BccFoldering: 15.20.1361.017 X-Microsoft-Exchange-Diagnostics: 1;DM6PR04MB4700;9:LMy1H5f4+7O1uMkes8FrWk2N8gbopWSP6+cjRup30744qD+78zRcEGnT9E7nTyLS5enuc1JtLCfxfCjW7LmzbQ7Ar2ua6VJJWBACR569iDLJXjfFg7gmtQGOLqxnfGU+ X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:1;ex:0;auth:0;dest:J;ENG:(20160513016)(750119)(520011016)(944506303)(944626516); X-Microsoft-Antispam-Message-Info: =?us-ascii?Q?p/NPztEKjroyOKXtWhwSEEQtVUArTobJoksWu3NG/GD40y0zQHQaYbxYuQbX?= =?us-ascii?Q?b2MI1ger5CuICj/tOOrt+aYN3C8YfDN+3oBlgueA9bQpZLAZh5HvdZtBecPa?= =?us-ascii?Q?YwuYIG1U8irY/wdrxY9IABgZlysvrdiDWRmpu7kVPBZf2CojCCLlW1KqzulG?= =?us-ascii?Q?RtG9YLoO/Dau7TFF23AZJbAXVY80Z4FIA2+nraODbjhEXGf/QfzjJMSGCEIR?= =?us-ascii?Q?H6ICz9Lm1sQ3PUjDkyNTph6dr3YheXgd5Fwi83Bw0eBvtgf6FV/rA8ODqM61?= =?us-ascii?Q?fwq3Yaduqg5IbPY4Qe3F78+YHQk9/IDok8oNWKOGyUUQZoxbrOFaQCE/GE3W?= =?us-ascii?Q?e4XA2dSUzZoU5QpHTwpZnYGN2TqgCcdbp2QQweO+lKSHZQGIGdi6VWLP1MXZ?= =?us-ascii?Q?ALxL47F0l7AQGePPjSNXzgW9GD8DNWVjSm9MxbiC0CHy9zD5VlycKS6WgqLA?= =?us-ascii?Q?YrW5Uqso/CFV+Hmw+KIBihR/ph/4qXCcEEkCI+TPJHr4kRmIde8as6WPbQ/g?= =?us-ascii?Q?LNF4PPgTRw0Umi3FcWB8N9lZHU+U1/6ryjRN7xvrFqb+X73lMxXCc7mVWwe9?= =?us-ascii?Q?WiU95jbCRpqYZnQDYbVpSw4+/sL34dtFWdt3B2RjSbsiD9e0Mm1xHVEWXfSh?= =?us-ascii?Q?NE9IFvMwG+kIb1qvL/rj3zap37CIP06WhibPFKl0fs4nffY4oZ/no5sKeRJG?= =?us-ascii?Q?GrdcdS1u57nHd9psCrso7llLVOV/t2/Fx7qbVPRvCXWnKVI4WMnrhCIuk5li?= =?us-ascii?Q?HbYqN3cBweKmvK8ihPIFS0VArxAhYmARBDTF+Qailh1CR1FnemQVjhflLOoZ?= =?us-ascii?Q?+qzkwII5UHGfjfQzxmm5ixhmXUb1jw7F73rovpPN1e44kFt/GgK3vbv25r70?= =?us-ascii?Q?5DI3onZ/I5seDQoEDE6j5l99d01ulX4H1pWHiLCD292swl7pehiF9tK3C69p?= =?us-ascii?Q?4c2QEitQIdzU4Nucv3B1K2RMSPmTVb1HDExpJ+ihV6KmChC7rFZhXJAC5YHs?= =?us-ascii?Q?Y89pr6UvWZs2HsOB1Z/k7wQK5MVw28Z3UzHNWvk4vXNmQ6izBFtlG3bFaBCJ?= =?us-ascii?Q?UmxCoHnRd7xQfzaNR0GWWsGaAN12zjndyyFR/zWGl2qt4jJuOrtw1/XT/ktc?= =?us-ascii?Q?NJ9ebfcyS6YnnFqmGunL0Ctq+Oc1Y7y5MoCWM0PzbJxF2XhmMP3HGPg=3D?= X-Microsoft-Exchange-Diagnostics: 1;DM6PR04MB4700;27:X+2VnaN3mzkDvp1v4Bjhyuyeln28lYWlaODJm4zxIsZKtiLclm8BWmOFYBGblIXhCfwvknDou6nV6U6hsUQwpGWXwbYTsaeT9YlHP34ifWMbIg+/oy78l5qcn7PhjJzb3kK+K8tvOjp0IC1dfYbSqHtYlHQzBvxNwoZMY9l47BYcoXqNw3X8W8YINWjPvXTxfIa3TykCZGbZJdLlhBRaw/xuDowPabU+P1ENo5PFqu1UcY6m8mLf8XGjPGH8yaMC8Un9gZ1J5bsSymeVqA0ORxPOjEBiPn4bHlZGCOP0J/4MRV6R7Sqkwk5iDH+kMyIF0uP9pJrnloUaqNfouegRWbitT/t9mr8WF80NodclhpExurho6xtf6aUaobwaaV4y90iao1In1Hshv3RfoR7/eA== Content-type: multipart/mixed; boundary="B_3626894988_1049324633" > This message is in MIME format. Since your mail reader does not understand this format, some or all of this message may not be legible. --B_3626894988_1049324633 Content-type: multipart/alternative; boundary="B_3626894988_1494966910" --B_3626894988_1494966910 Content-type: text/plain; charset="UTF-8" Content-transfer-encoding: quoted-printable Hello Phil,=20 Perfect, I've attached a counter-signed agreement. We're good to go with 3 = days, just let us know when. In the meantime, have a great weekend! Dan Dan Leung =20 Executive Producer | Cinematographer =20 Office: (267) 607-3455 =20 Cell: (610) 710-6092 =20 www.fivefivecollective.com =20 Five Five Collective, 1639 N Hancock St STE 310, Philadelphia, PA=20 On Fri, Nov 30, 2018 at 3:30 PM Stoltzfus, Phillip <Phillip.Stoltzfus@pennm= edicine.upenn.edu> wrote: Please see attached. =20 Best, Phil =20 From: Stoltzfus, Phillip=20 Sent: Friday, November 30, 2018 11:38 AM To: 'Dan Leung' <dan@fivefivecollective.com> Cc: 'Max Goldberg' <max@fivefivecollective.com>; Curran, Matt <Matt.Curran@= pennmedicine.upenn.edu> Subject: RE: [External] Re: 2018-19 Accelerator Fund Videos =20 Good morning, =20 We will have the signed agreement shortly for three days=E2=80=A6 and are working= on determining our physician availability for January. =20 Thanks, Phil =20 From: Stoltzfus, Phillip=20 Sent: Friday, November 16, 2018 5:11 PM To: 'Dan Leung' <dan@fivefivecollective.com> Cc: Max Goldberg <max@fivefivecollective.com>; Curran, Matt <Matt.Curran@pe= nnmedicine.upenn.edu> Subject: RE: [External] Re: 2018-19 Accelerator Fund Videos =20 Interesting, it was in my spam folder. Thank you. We will be in touch =20 Phil =20 From: Dan Leung <dan@fivefivecollective.com>=20 Sent: Friday, November 16, 2018 5:06 PM To: Stoltzfus, Phillip <Phillip.Stoltzfus@pennmedicine.upenn.edu> Cc: Max Goldberg <max@fivefivecollective.com>; Curran, Matt <Matt.Curran@pe= nnmedicine.upenn.edu> Subject: Re: [External] Re: 2018-19 Accelerator Fund Videos =20 Hi Phillip, =20 I thought I attached the agreement 4 days ago, but here it is again. =20 Dan Leung =20 Executive Producer | Cinematographer Office: (267) 607-3455 =20 Cell: (610) 710-6092 =20 www.fivefivecollective.com =20 Five Five Collective, 1639 N Hancock St STE 310, Philadelphia, PA=20 =20 =20 On Fri, Nov 16, 2018 at 5:01 PM Stoltzfus, Phillip <Phillip.Stoltzfus@pennm= edicine.upenn.edu> wrote: Following up=E2=80=A6 =20 Thanks, Phil =20 From: Stoltzfus, Phillip=20 Sent: Monday, November 12, 2018 10:11 AM To: 'Dan Leung' <dan@fivefivecollective.com> Cc: Max Goldberg <max@fivefivecollective.com>; Curran, Matt <Matt.Curran@pe= nnmedicine.upenn.edu>; Lubin, Joshua T <Joshua.Lubin@uphs.upenn.edu> Subject: RE: [External] Re: 2018-19 Accelerator Fund Videos =20 Thank you. Could you please send an agreement with 2, 2.5 and 3 day tier p= ricing? As Matt noted, the number of days we=E2=80=99ll need will depend on our s= cheduling of the participants. =20 Thanks, Phil =20 From: Dan Leung <dan@fivefivecollective.com>=20 Sent: Thursday, November 08, 2018 2:10 PM To: Curran, Matt <Matt.Curran@pennmedicine.upenn.edu> Cc: Stoltzfus, Phillip <Phillip.Stoltzfus@pennmedicine.upenn.edu>; Max Gold= berg <max@fivefivecollective.com> Subject: Re: [External] Re: 2018-19 Accelerator Fund Videos =20 LIke Matt said, it's not impossible, there's certainly enough time in a 10h= r production day for 3/4/5 doctors per day. I don't think back-to-back is ne= cessary, though. =20 Also, a half day would not be half the price of a production day. 1 day ~ $= 2,250 whereas 1/2 day ~$1850. =20 Dan Leung =20 Executive Producer | Cinematographer Office: (267) 607-3455 =20 Cell: (610) 710-6092 =20 www.fivefivecollective.com =20 Five Five Collective, 1639 N Hancock St STE 310, Philadelphia, PA=20 =20 =20 On Thu, Nov 8, 2018 at 2:05 PM Curran, Matt <Matt.Curran@pennmedicine.upenn= .edu> wrote: I=E2=80=99d say its doable, but only if we can line up docs back-to-back on 2 day= s. My experience tells me it=E2=80=99s unlikely, but logistically possible. There = would be enough time each day to make this happen. =20 =20 --- =20 Matt Curran Manager, Digital Video Strategy Penn Medicine Strategic Marketing Services Cell: 215-906-9095 |Office: 215-615-0280 3600 Market St. Suite 210 | Philadelphia, PA 19104 *NEW EMAIL* Matt.Curran@pennmedicine.upenn.edu =20 From: "Stoltzfus, Phillip" <Phillip.Stoltzfus@pennmedicine.upenn.edu> Date: Thursday, November 8, 2018 at 1:59 PM To: Dan Leung <dan@fivefivecollective.com> Cc: "Curran, Matt" <Matt.Curran@pennmedicine.upenn.edu>, Max Goldberg <max@= fivefivecollective.com> Subject: RE: [External] Re: 2018-19 Accelerator Fund Videos =20 For the group: can we do 8 videos in 2 or 2.5 days? =20 Thanks, Phil =20 From: Dan Leung <dan@fivefivecollective.com>=20 Sent: Thursday, November 08, 2018 12:23 PM To: Stoltzfus, Phillip <Phillip.Stoltzfus@pennmedicine.upenn.edu> Cc: Curran, Matt <Matt.Curran@pennmedicine.upenn.edu>; Max Goldberg <max@fi= vefivecollective.com> Subject: [External] Re: 2018-19 Accelerator Fund Videos =20 Hello Phil, =20 Thank you for reaching out again! We really enjoy making this series! =20 Here are the previous final scripts. PCPM Faculty Teleprompter Scripts =20 Before I update the agreement, I have a few points: Last round, we had 3 shooting days. I don't think that needs to change. When is the deadline? Last round was a little under 2 months turnaround. Our rates have slightly raised since the last round. Total estimate: $16,79= 0, ~$2,000 more than last round. Is this okay? Please let me know your answers and we'd love to get started. Dan =20 Dan Leung =20 Executive Producer | Cinematographer Office: (267) 607-3455 =20 Cell: (610) 710-6092 =20 www.fivefivecollective.com =20 Five Five Collective, 1639 N Hancock St STE 310, Philadelphia, PA=20 =20 =20 On Tue, Nov 6, 2018 at 5:05 PM Stoltzfus, Phillip <Phillip.Stoltzfus@pennme= dicine.upenn.edu> wrote: Hi Dan, =20 I am assisting the Penn Center for Precision Medicine in producing the next= round of Accelerator Fund explainer videos. We would like to shoot in Decem= ber, if feasible, and will book the PCAM studio based on physician availabil= ity (gathering now). There will be eight videos in this round. Could you = work up an updated agreement? Also, do you happen to have the final previou= s video scripts? (We=E2=80=99ll attempt to track down on our end as well, but Da= niel Wild is out of country and not fully accessible)=20 =20 Anything else we need to discuss? =20 Many thanks, Phil =20 Phillip Stoltzfus Marketing Communications 3600 Market Street, Suite 240 Philadelphia, PA 19104 Tel: 267-254-7861 | Fax: 215-614-0048 Email: phillip.stoltzfus@uphs.upenn.edu =20 =20 --B_3626894988_1494966910 Content-type: text/html; charset="UTF-8" Content-transfer-encoding: quoted-printable <html> <head> <meta http-equiv=3D"Content-Type" content=3D"text/html; charset=3Dutf-8"> </head> <body> <div dir=3D"ltr">Hello Phil, <div><br> </div> <div>Perfect, I've attached a counter-signed agreement. We're good to = go with 3 days, just let us know when.</div> <div><br> </div> <div>In the meantime, have a great weekend!</div> <div>Dan<br clear=3D"all"> <div> <div dir=3D"ltr" class=3D"gmail_signature" data-smartmail=3D"gmail_signature"> <div dir=3D"ltr"> <div> <div dir=3D"ltr"> <div> <div dir=3D"ltr"> <div> <div dir=3D"ltr"> <div> <div dir=3D"ltr"> <div dir=3D"ltr"> <div dir=3D"ltr"> <div dir=3D"ltr"><br style=3D"color:rgb(0,0,0);font-family:Times;font-size:medi= um"> <table cellpadding=3D"0" cellspacing=3D"0" style=3D"font-size:12.8px;margin:0px 0= px 15px;padding:0px;color:rgb(90,90,90);font-family:"Helvetica Neue&quo= t;,Helvetica,Arial,sans-serif"> <tbody> <tr> <td style=3D"font-family:"Helvetica Neue",Helvetica,Arial,sans-seri= f;vertical-align:top;font-size:12.8px;width:70px;padding-bottom:15px"> <a href=3D"https://www.fivefivecollective.com/" target=3D"_blank"><img src=3D"htt= ps://static1.squarespace.com/static/5aa1a2c696e76fd81f70eb3a/t/5ad6626f562fa= 7785d111b5b/1523999344190/fivefivesig.gifw%22" width=3D"92" height=3D"92"></a><b= r> </td> <td style=3D"vertical-align:top;height:90px;padding:0px 0px 15px 15px"> <p style=3D"margin-top:0px;padding-top:0px"><font face=3D"arial, helvetica, san= s-serif" size=3D"2"><span style=3D"color:rgb(62,94,99)"><b>Dan Leung </b>&n= bsp;</span> <br> <span style=3D"text-transform:capitalize"><b>Executive Producer | Cinematogra= pher </b> </span> <br> </font></p> <p style=3D"margin-top:10px;padding-top:0px;margin-bottom:0px;padding-bottom:= 0px"><font face=3D"arial, helvetica, sans-serif" size=3D"2">Office: &= nbsp;(267) 607-3455 <br> Cell: (610) 710-6092 <br> <a href=3D"https://www.fivefivecollective.com/" style=3D"color:rgb(62,94,99)" t= arget=3D"_blank">www.fivefivecollective.com</a> <br> </font></p> </td> </tr> <tr style=3D"min-width:350px;margin:0px;padding:0px"> <td colspan=3D"2" style=3D"vertical-align:top;border-top:1px solid rgb(197,197,= 197)"> <p style=3D"margin-top:0px;padding:10px 0px 0px"><font face=3D"arial, helvetica= , sans-serif" size=3D"2">Five Five Collective, <a href=3D"https://goo.gl/ma= ps/rBitcXLdsbq" style=3D"color:rgb(62,94,99)" target=3D"_blank"> 1639 N Han= cock St STE 310, Philadelphia, PA</a></font></p> </td> </tr> </tbody> </table> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> <br> </div> </div> <br> <div class=3D"gmail_quote"> <div dir=3D"ltr">On Fri, Nov 30, 2018 at 3:30 PM Stoltzfus, Phillip <<a hr= ef=3D"mailto:Phillip.Stoltzfus@pennmedicine.upenn.edu">Phillip.Stoltzfus@pennm= edicine.upenn.edu</a>> wrote:<br> </div> <blockquote class=3D"gmail_quote" style=3D"margin:0 0 0 .8ex;border-left:1px #c= cc solid;padding-left:1ex"> <div lang=3D"EN-US" link=3D"blue" vlink=3D"purple"> <div class=3D"m_6605254778740675584WordSection1"> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Please see attached.<u></u><u></u></span><= /p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"><u></u> <u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Best,<u></u><u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Phil<u></u><u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"><u></u> <u></u></span></p> <div> <div style=3D"border:none;border-top:solid #e1e1e1 1.0pt;padding:3.0pt 0in 0i= n 0in"> <p class=3D"MsoNormal"><b><span style=3D"font-size:11.0pt;font-family:"Cal= ibri",sans-serif">From:</span></b><span style=3D"font-size:11.0pt;font-fa= mily:"Calibri",sans-serif"> Stoltzfus, Phillip <br> <b>Sent:</b> Friday, November 30, 2018 11:38 AM<br> <b>To:</b> 'Dan Leung' <<a href=3D"mailto:dan@fivefivecollective.com" targ= et=3D"_blank">dan@fivefivecollective.com</a>><br> <b>Cc:</b> 'Max Goldberg' <<a href=3D"mailto:max@fivefivecollective.com" t= arget=3D"_blank">max@fivefivecollective.com</a>>; Curran, Matt <<a href=3D= "mailto:Matt.Curran@pennmedicine.upenn.edu" target=3D"_blank">Matt.Curran@penn= medicine.upenn.edu</a>><br> <b>Subject:</b> RE: [External] Re: 2018-19 Accelerator Fund Videos<u></u><u= ></u></span></p> </div> </div> <p class=3D"MsoNormal"><u></u> <u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Good morning,<u></u><u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"><u></u> <u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">We will have the signed agreement shortly = for three days=E2=80=A6 and are working on determining our physician availability = for January.<u></u><u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"><u></u> <u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Thanks,<u></u><u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Phil<u></u><u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"><u></u> <u></u></span></p> <div> <div style=3D"border:none;border-top:solid #e1e1e1 1.0pt;padding:3.0pt 0in 0i= n 0in"> <p class=3D"MsoNormal"><b><span style=3D"font-size:11.0pt;font-family:"Cal= ibri",sans-serif">From:</span></b><span style=3D"font-size:11.0pt;font-fa= mily:"Calibri",sans-serif"> Stoltzfus, Phillip <br> <b>Sent:</b> Friday, November 16, 2018 5:11 PM<br> <b>To:</b> 'Dan Leung' <<a href=3D"mailto:dan@fivefivecollective.com" targ= et=3D"_blank">dan@fivefivecollective.com</a>><br> <b>Cc:</b> Max Goldberg <<a href=3D"mailto:max@fivefivecollective.com" tar= get=3D"_blank">max@fivefivecollective.com</a>>; Curran, Matt <<a href=3D"m= ailto:Matt.Curran@pennmedicine.upenn.edu" target=3D"_blank">Matt.Curran@pennme= dicine.upenn.edu</a>><br> <b>Subject:</b> RE: [External] Re: 2018-19 Accelerator Fund Videos<u></u><u= ></u></span></p> </div> </div> <p class=3D"MsoNormal"><u></u> <u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Interesting, it was in my spam folder.&nbs= p; Thank you. We will be in touch<u></u><u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"><u></u> <u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Phil<u></u><u></u></span></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"><u></u> <u></u></span></p> <p class=3D"MsoNormal"><b><span style=3D"font-size:11.0pt;font-family:"Cal= ibri",sans-serif">From:</span></b><span style=3D"font-size:11.0pt;font-fa= mily:"Calibri",sans-serif"> Dan Leung <<a href=3D"mailto:dan@five= fivecollective.com" target=3D"_blank">dan@fivefivecollective.com</a>> <br> <b>Sent:</b> Friday, November 16, 2018 5:06 PM<br> <b>To:</b> Stoltzfus, Phillip <<a href=3D"mailto:Phillip.Stoltzfus@pennmed= icine.upenn.edu" target=3D"_blank">Phillip.Stoltzfus@pennmedicine.upenn.edu</a= >><br> <b>Cc:</b> Max Goldberg <<a href=3D"mailto:max@fivefivecollective.com" tar= get=3D"_blank">max@fivefivecollective.com</a>>; Curran, Matt <<a href=3D"m= ailto:Matt.Curran@pennmedicine.upenn.edu" target=3D"_blank">Matt.Curran@pennme= dicine.upenn.edu</a>><br> <b>Subject:</b> Re: [External] Re: 2018-19 Accelerator Fund Videos<u></u><u= ></u></span></p> <p class=3D"MsoNormal"><u></u> <u></u></p> <div> <p class=3D"MsoNormal">Hi Phillip,<u></u><u></u></p> <div> <p class=3D"MsoNormal"><u></u> <u></u></p> </div> <div> <p class=3D"MsoNormal">I thought I attached the agreement 4 days ago, but her= e it is again.<br clear=3D"all"> <u></u><u></u></p> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <p class=3D"MsoNormal"><u></u> <u></u></p> <table class=3D"m_6605254778740675584MsoNormalTable" border=3D"0" cellspacing=3D"= 0" cellpadding=3D"0"> <tbody> <tr style=3D"height:67.5pt"> <td width=3D"102" valign=3D"top" style=3D"width:52.5pt;padding:0in 0in 11.25pt 0i= n;height:67.5pt"> <p class=3D"MsoNormal" style=3D"margin-bottom:11.25pt"><span style=3D"font-size:9= .5pt;font-family:"Helvetica",sans-serif;color:#5a5a5a"><a href=3D"ht= tps://www.fivefivecollective.com/" target=3D"_blank"><span style=3D"text-decorat= ion:none"><img border=3D"0" width=3D"92" height=3D"92" style=3D"width:.9583in;height= :.9583in" id=3D"m_6605254778740675584_x0000_i1025" src=3D"https://static1.square= space.com/static/5aa1a2c696e76fd81f70eb3a/t/5ad6626f562fa7785d111b5b/1523999= 344190/fivefivesig.gifw%22"></span></a><u></u><u></u></span></p> </td> <td valign=3D"top" style=3D"padding:0in 0in 11.25pt 11.25pt;height:67.5pt"> <p style=3D"margin-top:0in"><b><span style=3D"font-size:10.0pt;font-family:&quo= t;Arial",sans-serif;color:#3e5e63">Dan Leung </span></b><span styl= e=3D"font-size:10.0pt;font-family:"Arial",sans-serif;color:#3e5e63">= </span><span style=3D"font-size:10.0pt;font-family:"Arial",san= s-serif;color:#5a5a5a"> <br> <b>Executive Producer | Cinematographer </b> </span><span s= tyle=3D"font-size:9.5pt;font-family:"Helvetica",sans-serif;color:#5a= 5a5a"><u></u><u></u></span></p> <p style=3D"margin-right:0in;margin-bottom:0in;margin-left:0in;margin-bottom:= .0001pt"> <span style=3D"font-size:10.0pt;font-family:"Arial",sans-serif;colo= r:#5a5a5a">Office: (267) 607-3455 <br> Cell: (610) 710-6092 <br> <a href=3D"https://www.fivefivecollective.com/" target=3D"_blank"><span style=3D"= color:#3e5e63">www.fivefivecollective.com</span></a> </span><span= style=3D"font-size:9.5pt;font-family:"Helvetica",sans-serif;color:#= 5a5a5a"><u></u><u></u></span></p> </td> </tr> <tr style=3D"min-width:350px"> <td colspan=3D"2" valign=3D"top" style=3D"border:none;border-top:solid #c5c5c5 1.= 0pt;padding:0in 0in 0in 0in"> <p style=3D"margin-top:0in"><span style=3D"font-size:10.0pt;font-family:"A= rial",sans-serif;color:#5a5a5a">Five Five Collective, <a href=3D"htt= ps://goo.gl/maps/rBitcXLdsbq" target=3D"_blank"><span style=3D"color:#3e5e63">&n= bsp;1639 N Hancock St STE 310, Philadelphia, PA</span></a></span><span style= =3D"font-size:9.5pt;font-family:"Helvetica",sans-serif;color:#5a5a5a= "><u></u><u></u></span></p> </td> </tr> </tbody> </table> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> <p class=3D"MsoNormal"><u></u> <u></u></p> </div> </div> <p class=3D"MsoNormal"><u></u> <u></u></p> <div> <div> <p class=3D"MsoNormal">On Fri, Nov 16, 2018 at 5:01 PM Stoltzfus, Phillip <= ;<a href=3D"mailto:Phillip.Stoltzfus@pennmedicine.upenn.edu" target=3D"_blank">P= hillip.Stoltzfus@pennmedicine.upenn.edu</a>> wrote:<u></u><u></u></p> </div> <blockquote style=3D"border:none;border-left:solid #cccccc 1.0pt;padding:0in = 0in 0in 6.0pt;margin-left:4.8pt;margin-top:5.0pt;margin-right:0in;margin-bot= tom:5.0pt"> <div> <div> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Following up=E2=80=A6</span><u></u><u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"> </span><u></u><u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Thanks,</span><u></u><u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Phil</span><u></u><u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"> </span><u></u><u></u></p> <div> <div style=3D"border:none;border-top:solid #e1e1e1 1.0pt;padding:3.0pt 0in 0i= n 0in"> <p class=3D"MsoNormal"><b><span style=3D"font-size:11.0pt;font-family:"Cal= ibri",sans-serif">From:</span></b><span style=3D"font-size:11.0pt;font-fa= mily:"Calibri",sans-serif"> Stoltzfus, Phillip <br> <b>Sent:</b> Monday, November 12, 2018 10:11 AM<br> <b>To:</b> 'Dan Leung' <<a href=3D"mailto:dan@fivefivecollective.com" targ= et=3D"_blank">dan@fivefivecollective.com</a>><br> <b>Cc:</b> Max Goldberg <<a href=3D"mailto:max@fivefivecollective.com" tar= get=3D"_blank">max@fivefivecollective.com</a>>; Curran, Matt <<a href=3D"m= ailto:Matt.Curran@pennmedicine.upenn.edu" target=3D"_blank">Matt.Curran@pennme= dicine.upenn.edu</a>>; Lubin, Joshua T <<a href=3D"mailto:Joshua.Lubin@uphs.upenn.edu" target=3D"_blank">Joshua.Lu= bin@uphs.upenn.edu</a>><br> <b>Subject:</b> RE: [External] Re: 2018-19 Accelerator Fund Videos</span><u= ></u><u></u></p> </div> </div> <p class=3D"MsoNormal"> <u></u><u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Thank you. Could you please send an = agreement with 2, 2.5 and 3 day tier pricing? As Matt noted, the numbe= r of days we=E2=80=99ll need will depend on our scheduling of the participants.</span><u></u><u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"> </span><u></u><u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Thanks,</span><u></u><u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d">Phil</span><u></u><u></u></p> <p class=3D"MsoNormal"><span style=3D"font-size:11.0pt;font-family:"Calibr= i",sans-serif;color:#1f497d"> </span><u></u><u></u></p> <p class=3D"MsoNormal"><b><span style=3D"font-size:11.0pt;font-family:"Cal= ibri",sans-serif">From:</span></b><span style=3D"font-size:11.0pt;font-fa= mily:"Calibri",sans-serif"> Dan Leung <<a href=3D"mailto:dan@five= fivecollective.com" target=3D"_blank">dan@fivefivecollective.com</a>> <br> <b>Sent:</b> Thursday, November 08, 2018 2:10 PM<br> <b>To:</b> Curran, Matt <<a href=3D"mailto:Matt.Curran@pennmedicine.upenn.= edu" target=3D"_blank">Matt.Curran@pennmedicine.upenn.edu</a>><br> <b>Cc:</b> Stoltzfus, Phillip <<a href=3D"mailto:Phillip.Stoltzfus@pennmed= icine.upenn.edu" target=3D"_blank">Phillip.Stoltzfus@pennmedicine.upenn.edu</a= >>; Max Goldberg <<a href=3D"mailto:max@fivefivecollective.com" target=3D"= _blank">max@fivefivecollective.com</a>><br> <b>Subject:</b> Re: [External] Re: 2018-19 Accelerator Fund Videos</span><u= ></u><u></u></p> <p class=3D"MsoNormal"> <u></u><u></u></p> <div> <p class=3D"MsoNormal">LIke Matt said, it's not impossible, there's certainly= enough time in a 10hr production day for 3/4/5 doctors per day. I don't thi= nk back-to-back is necessary, though.<u></u><u></u></p> <div> <p class=3D"MsoNormal"> <u></u><u></u></p> </div> <div> <p class=3D"MsoNormal">Also, a half day would not be half the price of a prod= uction day. 1 day ~ $2,250 whereas 1/2 day ~$1850.<u></u><u></u></p> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <div> <p class=3D"MsoNormal"> <u></u><u></u></p> <table class=3D"m_6605254778740675584MsoNormalTable" border=3D"0" cellspacing=3D"= 0" cellpadding=3D"0"> <tbody> <tr style=3D"height:67.5pt"> <td width=3D"102" valign=3D"top" style=3D"width:52.5pt;padding:0in 0in 11.25pt 0i= n;height:67.5pt"> <p class=3D"MsoNormal" style=3D"margin-bottom:11.25pt"><span style=3D"font-size:9= .5pt;font-family:"Helvetica",sans-serif;color:#5a5a5a"><a href=3D"ht= tps://www.fivefivecollective.com/" target=3D"_blank"><span style=3D"text-decorat= ion:none"><img border=3D"0" width=3D"92" height=3D"92" style=3D"width:.9583in;height= :.9583in" id=3D"m_6605254778740675584m_-2331683335732289386_x005f_x0000_i1025"= src=3D"https://static1.squarespace.com/static/5aa1a2c696e76fd81f70eb3a/t/5ad6= 626f562fa7785d111b5b/1523999344190/fivefivesig.gifw%22"></span></a></span><u= ></u><u></u></p> </td> <td valign=3D"top" style=3D"padding:0in 0in 11.25pt 11.25pt;height:67.5pt"> <p style=3D"margin-top:0in"><b><span style=3D"font-size:10.0pt;font-family:&quo= t;Arial",sans-serif;color:#3e5e63">Dan Leung </span></b><span styl= e=3D"font-size:10.0pt;font-family:"Arial",sans-serif;color:#3e5e63">= </span><span style=3D"font-size:10.0pt;font-family:"Arial",san= s-serif;color:#5a5a5a"> <br> <b>Executive Producer | Cinematographer </b> </span><u></u>= <u></u></p> <p style=3D"margin-bottom:0in;margin-bottom:.0001pt"><span style=3D"font-size:1= 0.0pt;font-family:"Arial",sans-serif;color:#5a5a5a">Office: &= nbsp; (267) 607-3455 <br> Cell: (610) 710-6092 <br> <a href=3D"https://www.fivefivecollective.com/" target=3D"_blank"><span style=3D"= color:#3e5e63">www.fivefivecollective.com</span></a> </span><u></= u><u></u></p> </td> </tr> <tr style=3D"min-width:350px"> <td colspan=3D"2" valign=3D"top" style=3D"border:none;border-top:solid #c5c5c5 1.= 0pt;padding:0in 0in 0in 0in"> <p style=3D"margin-top:0in"><span style=3D"font-size:10.0pt;font-family:"A= rial",sans-serif;color:#5a5a5a">Five Five Collective, <a href=3D"htt= ps://goo.gl/maps/rBitcXLdsbq" target=3D"_blank"><span style=3D"color:#3e5e63">&n= bsp;1639 N Hancock St ST
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement
